Presentation Information
[LMO1-4]Immunological analysis in a phase I study of herpesvirus G47Δ for cancer therapy in patients with malignant pleural mesothelioma
Yoshinori Sakata1, Minoru Tanaka1, Norihiko Ikeda2, Tomoki Todo1 (1.Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2.Department of Thoracic Surgery, Tokyo Medical University, Tokyo, Japan)
Password required to view
Comment
To browse or post comments, you must log in.Log in